Wednesday, August 6, 2025
HomeStockDazheng Group persists in Hollysys takeover bid at $29.50 per share By...

Dazheng Group persists in Hollysys takeover bid at $29.50 per share By Investing.com



© Reuters.

HONG KONG – A consortium led by Dazheng Group Acquisition Restricted has reaffirmed its intention to amass Hollysys Automation (NASDAQ:) Applied sciences Ltd. (NASDAQ: HOLI), providing shareholders a premium over the competing Ascendent Capital bid. The consortium’s unwavering provide of $29.50 per share stands as an 11.3% premium to Ascendent’s proposal, aiming to supply Hollysys shareholders with a extra assured closing.

The consortium, which incorporates Dazheng Group and TFI Asset Administration Restricted, has secured monetary commitments that surpass business norms, with a $1.05 billion debt dedication from a distinguished PRC-headquartered financial institution and $800 million in fairness commitments. These commitments are backed by sturdy proof of funding, together with financial institution statements and formally executed fairness dedication letters, offering a closing certainty that the consortium claims is superior to that of Ascendent’s provide.

Negotiations between Hollysys and the consortium started on January 28, 2024, as acknowledged by the Particular Committee in a proxy assertion complement. The consortium argues that the Particular Committee’s recognition of their proposal implies its superiority or potential superiority over Ascendent’s bid. Nevertheless, the Particular Committee has not really useful an adjournment of the Extraordinary Normal Assembly (EGM) scheduled for February 8, 2024, to contemplate the consortium’s provide. Because of this, the consortium is urging shareholders to vote AGAINST the Ascendent transaction to safe the potential for exiting at $29.50 per share.

Main Proxy Advisors, Institutional Shareholder Providers (ISS) and Glass Lewis, have really useful that shareholders vote towards the Ascendent transaction, citing issues over the gross sales course of and the Particular Committee’s actions. The consortium emphasizes that rejection of the Ascendent deal wouldn’t incur a termination payment for Hollysys and maintains {that a} vote towards it’s within the shareholders’ finest curiosity.

The consortium has additionally highlighted the significance of not voting for the Ascendent transaction to protect dissenting and appraisal rights beneath Part 179 of the British Virgin Islands Enterprise Firms Act. This reminder is available in mild of the lack of knowledge on these rights in Hollysys’s proxy assertion.

This information relies on a press launch assertion from Dazheng Group Acquisition Restricted.

This text was generated with the assist of AI and reviewed by an editor. For extra info see our T&C.

RELATED ARTICLES

Most Popular

Recent Comments